Apri score calculator for hepatitis b. 2015, WHO) Evidence of significant fibrosis (≥F2) based on an APRI score of >0. In a meta-analysis by Lin et al, it was found that in patients with hepatitis C, an APRI score greater than 1. Jul 1, 2023 · As shown in viral hepatitis, inflammation, affecting NITs using transaminases, such as FIB-4, NFS, and APRI, as well as LSM, whatever the technique, is a major confounding factor. Table 1. Most experts recommend using 40 IU/L as the value for the AST upper limit of normal when calculating an APRI value. 0 FIB-4 FIB-4 = (age [years] × AST [U/L]) ÷ (platelet count [× 109/L] × √ALT [U/L]) Online An ideal risk score will be easy to use, cheap, and accurate. 48, then a liver biopsy may be warranted to determine the presence or absence of advanced fibrosis/cirrhosis and the need for routine hepatocellular cancer surveillance and follow-up. It helps medical professionals evaluate the potential presence of liver scarring, known as fibrosis. Most laboratories use 40 IU/L as the value for the AST upper limit of normal. Diabetic/obese patients showed lower APRI, FIB-4, and liver stiffness (EKPa) values compared to other subgroups. Oct 1, 2017 · The AST-to-Platelet Ratio Index (APRI) and fibrosis 4 calculator (FIB-4) score were originally designed for patients with chronic hepatitis C virus (HCV) infection, but several studies have demonstrated reasonable utility in assessing fibrosis in NAFLD patients, as well [9], [10]. APRI score measures the amount of fibrosis in the liver. Performance of both scores was influenced by age, the body mass index, and cytolysis. As shown in this table, FibroTest needs several specific tests such as haptoglobin, A1apoprotein and alpha2-macroglobulin at designated laboratories and the test is commercially patented. Conclusions In this study, patients with severe fibrosis or cirrhosis were found to have a higher FIB-4 value than APRI in the context of chronic hepatitis C. Calculate APRI (AST to Platelet Ratio Index): Explanation and Clinical Context The APRI score is a non-invasive index to predict the presence of liver fibrosis and cirrhosis, originally validated in patients with chronic hepatitis C. Non-invasive serum markers for assessing liver fibrosis stage currently available in Australia Method Formula Key threshold for excluding cirrhosis* APRI APRI = (AST [IU/L] ÷ AST ULN [IU/L] × 100) ÷ platelet count ( × 109/L) Online calculator APRI < 1. Using our APRI Calculator, medical professionals can easily and quickly calculate the APRI score, which is a non-invasive way to assess liver damage in patients with hepatitis C. One hundred twenty-three patients who underwent liver biopsy due to chronic hepatitis B were included in the study. Find out more about what it is, how it’s calculated, and why doctors use it instead of biopsies. Enter the required values to calculate the APRI value. It uses two standard laboratory tests: the AST level and the platelet count. AST to Platelet Ratio Index (APRI) Calculator Share This is an A ST to P latelet R atio I ndex (APRI) calculator tool. 5 kPa indicates cirrhosis 1 APRI score (AST-to-platelet ratio) when elastography is unavailable; APRI > 0. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B. It offers a non-invasive way to predict which patients have cirrhosis without imaging or biopsy. It is used in individuals with chronic hepatitis C or B to track liver health over time. Fibrosis-4 (FIB-4) Calculator Share The Fibrosis-4 score helps to estimate the amount of scarring in the liver. The NAFLD (Non-Alcoholic Fatty Liver Disease) Fibrosis Score estimates amount of scarring in the liver based on several laboratory tests. Non-Invasive Calculations to Predict Liver Damage APRI and FIB-4 Talk to your doctor about using non-invasive calculations such as AST to Platelet Ratio Index (APRI) and Fibrosis-4 index for Liver Fibrosis (FIB-4) to determine if there is evidence of liver disease. It will appear in the oval on the far right (highlighted in yellow). The Feb 15, 2017 · Ucar F, Sezer S, Ginis Z, et al. We decided to add the functionality of the APRI calculator, so you can get a more complete assessment for your liver's condition. The FIB-4 and APRI scores were calculated for each patient and compared to histologically determined fibrosis stage. APRI What it measures: fibrosis Who should take it: anyone concerned about their liver Where to get it: primary care provider, online calculator AST to Platelet Ratio Index (APRI) is a blood-based liver test based on the amount of aspartate aminotransferase (AST) and platelets in a person’s body. ALBI and APRI scores, had better predictive accuracy than the previous traditional tools in assessing liver function, including Child-Pugh grade and MELD score. It is used especially for Hepatitis C and NASH correlated The Fibrosis-4 (FIB-4) Index for Liver Fibrosis is a non-invasive scoring system based on several laboratory tests that help to estimate the amount of scarring in the liver. The Fibrosis-4 (FIB-4) Index for Liver Fibrosis is a non-invasive scoring system based on several laboratory tests that help to estimate the amount of scarring in the liver. The APRI score is a simple, noninvasive marker for estimating liver fibrosis, calculated from common lab tests. Ask for a copy of blood test results which are required for use with these calculators. the most important factor in the prognosis and treatment plan of patients with chronic hepatitis B (CHB). ️ Read on to discover the Healthcare providers use the APRI score to guide treatment decisions and monitor liver health in various liver conditions, including hepatitis and cirrhosis. Select the applicable Clinical and Lab Criterias, then check the classification at the bottom. There are several risk scores out you may have heard about such as FIB-4 (Fibrosis-4), APRI (AST to platelet ratio index), and NFS (NAFLD fibrosis score). It’s a non-invasive way to assess liver damage, particularly in chronic hepatitis C patients. 5 is 92% specific but can miss almost two thirds with significant hepatic fibrosis (F2-F4). The AST to Platelet Ratio Index (APRI) predicts fibrosis and cirrhosis in hepatitis C patients. It is best validated for patients with Hepatitis C, but is also used in other chronic liver diseases. The present study has aimed to evaluate the effectiveness of FIB-4 and APRI to differentiate stages of liver fibrosis against fibroscan-based staging of liver stiffness in chronic hepatitis C infection. This is an A ST to P latelet R atio I ndex (APRI) calculator tool. 5 range, and the FibroSure/FibroTest is less than 0. (Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Free online tool for NAFLD screening, hepatitis evaluation, and advanced fibrosis detection with clinical interpretation. Screening Tool: The APRI score can serve as a screening tool to identify individuals at higher risk of significant hepatic fibrosis. FIB-4 score is a powerful instrument for ruling out or confirming a diagnosis of advanced fibrosis. Jul 25, 2025 · The APRI score calculator is a non-invasive tool used in healthcare to provide an initial assessment of liver health. It considers the platelet count and AST levels. APRI score may be useful to exclude cirrhosis in CHB patients. Calculate APRI score for liver fibrosis staging in hepatitis C and chronic liver diseases. The APRI Score will appear in the oval on the far right (highlighted in yellow). Non-invasive fibrosis assessment tool. May 5, 2025 · Simplified Fibrosis Assessment: This calculator demonstrates a simplified approach to assessing liver fibrosis in Hepatitis C. Jul 6, 2025 · What is the APRI Score? The APRI (AST to Platelet Ratio Index) is a simple, non-invasive scoring system used to estimate the degree of liver fibrosis in patients with chronic liver disease, most notably chronic hepatitis C. It offers an alternative to liver biopsy, which is more invasive and carries a risk of complications. 5 or greater, your liver likely has some damage. AST to Platelet Ratio Index (APRI), Fib-4 Score, and Pregnancy Outcome of Pregnant Women with Hepatitis B 1Division Desi of Gastroenterohepatology, Maghfirah,1 Fauzi Yusuf,1 Azzaki Abubakar,1 Medicine Department, Indonesia Dewi Karlina Rusly,2 Darnifayanti3 There are three common tests for assessing liver fibrosis – APRI (AST-to-platelet ratio index), FiB-4 (fibrosis-4 score) and FibroTest. Aspartate aminotransferase (AST)-to-platelet ratio index (APRI), fibrosis index based on 4 Apr 8, 2025 · Figures 2–4 present the median and interquartile ranges (25th–75th percentiles) of FibroScan, APRI, and FIB-4 scores across the entire cohort and subgroups, including alcoholic patients, diabetic/obese patients, and those with chronic hepatitis B and/or C. The aim was to assess the diagnostic accuracy of APRI and FIB-4 in assessing the stage of liver fibrosis in end stage renal disease (ESRD) patients with chronic viral hepatitis and to compare the two tests with standard tru-cut liver biopsy. A: Your APRI score provides an estimate of the extent of liver fibrosis or cirrhosis. If you have an APRI score of 1. Keywords: liver fibrosis, biomarkers, hepatitis C virus, FIB-4, APRI Introduction Hepatic C virus (HCV) infection can result in both acute and chronic hepatitis. 5 suggests significant fibrosis (≥F2) and > 1. It can be particularly useful in populations with risk factors for liver disease, such as chronic hepatitis C or B infections, excessive alcohol consumption, or metabolic conditions. The AST to Platelet Ratio Index (APRI) determines the likelihood of hepatic fibrosis and cirrhosis in patients with Hepatitis C. Enter AST, ULN, and platelet values to get instant screening results for chronic liver disease. This FIB-4 calculator is a simple tool for assessing the probability of NAFLD liver fibrosis. Assess the likelihood of cirrhosis in Hepatitis C patients using the APRI score, a reliable diagnostic tool. AST to Platelet Ratio Index (APRI) Calculator Share This is an A ST to P latelet R atio I ndex (APRI) calculator tool. WHO recommendations for the prevention, care and treatment of persons with chronic hepatitis B infection Non-invasive assessment of liver disease stage at baseline and during follow up: APRI (aspartate aminotransferase [AST]-to-platelet ratio index) is recommended as the preferred non-invasive test (NIT) to assess for the presence of cirrhosis (APRI score >2 in adults) in resource-limited The AST to Platelet Ratio Index (APRI score) (a calculated number using platelets and AST) The APRI is calculated to help measure liver health. Calculate FIB-4 and APRI scores to assess liver fibrosis risk. FIB-4 is the most used, so let’s do a deep dive into its origins… Where did FIB-4 come from? The AST to Platelet Ratio Index (APRI) tool has been found to useful as a non-invasive index that correlates with liver biopsy findings of fibrosis and cirrhosis. 2015, WHO) Calculate APRI score to assess liver fibrosis non-invasively. Aug 2, 2025 · The APRI score is applied in various clinical scenarios, particularly for monitoring patients with chronic liver conditions. Regular monitoring of APRI scores helps track fibrosis progression and the effectiveness of treatments in individuals with liver diseases. A simple noninvasiveindex can predict both significant fibrosis and cirrhosis in patientswith chronic hepatitis C. 0 suggests cirrhosis 1. The following indices were studied: “NAFLD fibrosis score (NFS), fibrosis-4 calculator (FIB-4), aspartate aminotransferase-to-alanine aminotransferase ratio (AST/ALT ratio), AST-to-platelet ratio index (APRI), and body mass index, AST/ALT ratio, and diabetes (BARD) score by age groups. 5 to 1. Mar 16, 2024 · For example, when an APRI score is in the 0. This is an AST to Platelet Ratio Index calculator tool. If your score is less than or equal to 0. e. The source for medical equations, algorithms, scores, and guidelines. It's most efficient in adults aged 35-65. Instructions Using the APRI Calculator tool, enter in the patient's laboratory data and calculate the patient's APRI score. Actual treatment decisions require comprehensive medical Child-Turcotte-Pugh (CTP) Calculator Share Use the Child-Turcotte-Pugh Classification for Severity of Cirrhosis calculator to estimate the cirrhosis severity. May 1, 2024 · Women with known coagulopathy; preeclampsia; hemolysis, elevated liver enzymes, low platelet count syndrome; acute hepatitis; and drug-induced liver injury were excluded from the study. The APRI score calculator helps clinicians decide if further diagnostic tests or liver AST to Platelet Ratio Index (APRI) Calculator Guide: What is APRI Score? The AST to Platelet Ratio Index (APRI) is a non-invasive marker for assessing liver fibrosis in patients with chronic liver disease, particularly hepatitis C. Hepatology 2003;38:518–526. Calculating a patient's APRI score allows clinicians to easily predict hepatic fibrosis without performing a more invasive medical tests, e. g. Clinical Care Options – Hepatitis Calculators APRI Calculator Child-Pugh Score for Cirrhosis Mortality Endmemo FIB-4 Calculator Martindale’s Calculators on-line Centre MELD Score (Model For End-Stage Liver Disease) (12 and older) Time and date calculators Guidelines/Decision makin g tools Decision-making in Viral Hepatitis related Advanced We would like to show you a description here but the site won’t allow us. This study showed that N/L ratio is negatively correlated with HAI in chronic hepatitis B (CHB). We would like to show you a description here but the site won’t allow us. AST is an enzyme that is typically Aug 8, 2013 · Neutrophil-lymphocyte (N/L) ratio is higher in patients with advanced fibrosis and considered as a novel non-invasive marker to predict advanced disease in non-alcoholic steatohepatitis. 5 kPa, regardless of HBV DNA or ALT levels. The APRI calculator computes the AST to Platelet Ratio Index (APRI), which we use to predict fibrosis and cirrhosis. Oct 3, 2024 · The APRI (AST to Platelet Ratio Index) score is a non-invasive tool used to assess the degree of fibrosis in the liver, especially in cases of hepatitis C. APRI score > 1. It combines two routine blood test values, aspartate aminotransferase (AST) and platelet count, to estimate the level of liver damage. , biopsy. Jul 1, 2021 · The results of the present study demonstrated two simple and noninvasive biomarker-based scores, i. Oct 8, 2025 · The AST to Platelet Ratio Index (APRI) is a simple, non-invasive test used to assess liver fibrosis and cirrhosis, especially in patients with chronic hepatitis B or C. A higher score correlates with a greater likelihood of significant fibrosis or cirrhosis. Oct 23, 2018 · Fibrosis testing is relevant for the clinical care of patients with chronic liver disease, including hepatitis B, hepatitis C (HCV), non-alcoholic fatty liver disease (NAFLD), co-infections, primary biliary cirrhosis, primary sclerosing cholangitis, and other chronic metabolic diseases of the liver. Mar 22, 2022 · Simple biomarker blood tests for fibrosis, including the aspartate aminotransferase-platelet ratio index (APRI) and fibrosis-4 index (FIB-4) score have been extensively validated and used given HEPATOLOGY 2006;43:1317- 1325. Conclusion: The APRI and FIB-4 scores had a good accuracy to exclude significant fibrosis in chronic hepatitis B virus infection. The APRI is a commonly used non-invasive marker, but it’s crucial to remember that this is a rudimentary calculation and clinical assessment is essential. 50 In practice, VCTE is probably the most attractive tool in terms of efficacy and cost-effectiveness. Although you can use the calculators The APRI Calculator uses two routine blood tests, AST (Aspartate Aminotransferase) and platelet count, to estimate liver fibrosis and cirrhosis. 2 days ago · Non-invasive fibrosis assessment using transient elastography (FibroScan); liver stiffness > 8 kPa indicates advanced fibrosis (≥F3) and > 12. Evaluate AST levels, platelet count, and predict fibrosis stages in chronic liver disease patients. Oct 1, 2024 · The APRI score helps detect liver fibrosis for people with liver disease. Answer the Activity Question based on the patient's APRI score. ”22 NFS and FIB-4 were found to best predict advanced Supplementary tables Supplementary Table 1. About APRI Calculator The AST to Platelet Ratio Index (APRI) is a validated non-invasive tool used to assess liver fibrosis risk in patients with chronic liver disease, particularly in viral hepatitis. Calculate APRI score to assess liver fibrosis non-invasively. Wai CT, Greenson JK, Fontana RJ, et al. The women's ALT, AST, and platelet numbers were assessed to calculate the FIB-4 score and APRI. 5, your liver is either completely free of brosis or has a tiny bit of scarring. This AST to platelet ratio index (APRI) calculator helps with cirrhosis diagnosis based on the platelet count and AST level. 5 or transient elastography value of >7 kPa or evidence of cirrhosis (F4) based on clinical criteria or an APRI score of >1 or transient elastography value of >12. Demographic and laboratory characteristics of the study population Methodology: One hundred and forty-two patients with chronic hepatitis C infection who underwent liver biopsy since January 1st 2014 until May 31st 2017 at the Hospital for Infectious and Tropical Diseases in Belgrade were analyzed. This Fibrosis 4 Fib4 score calculator employs the following formula: Fib 4 score = ( Age x AST ) / ( Platelet count x ( square root of ALT )) The Fibrosis 4 score This is a non invasive method based on clinical determinations that indicate the level of fibrosis/ scarring of the liver. Jul 21, 2025 · Use the APRI calculator to assess liver fibrosis or cirrhosis risk. Eur J Gastroenterol Hepatol 2013;25:1076-81. 0 had a sensitivity of 76% and specificity of 72% for predicting cirrhosis. Although you can use the calculators Centers for Disease Control and Prevention (CDC) Cooperative Agreement (CDC-RFA-PS21-2105) Conclusions In this study, patients with severe fibrosis or cirrhosis were found to have a higher FIB-4 value than APRI in the context of chronic hepatitis C. It is calculated using the formula: [ (AST / Upper Limit of Normal AST) / Platelet Count (10^9/L)] × 100. APRI, FIB-4, and FIB-5 scores of patients who underwent liver biopsy due to CHB were calculated by means of calculators and recorded to be compared with liver biopsies in terms of fibrosis scoring. It combines two readily available laboratory values: aspartate aminotransferase (AST) level and platelet count. Enter the required values to calculate the FIB-4 value. yyged ngyseh gbns gcqw yeml clgmyp hpe lcydm hifvxd dzxgs